Infantile hemangiomas may affect the quality of life (QoL) of patients and their family members, as anxiety and worry may commonly occur in parents, also linked to the social adversion they experience. We underline the beneficial impact of oral propranolol therapy on QoL of patients with infantile hemangiomas (IH) and of their relatives. A specific questionnaire measuring QoL was administered to parents of IH patients at beginning and end of a treatment with oral propranolol. Different aspects were investigated: site of the lesion, age of patients at starting therapy, length of treatment, occurrence of adverse effects and persistence/recurrence of the vascular anomaly. In all cases the questionnaire revealed a significant improvement of QoL, which was independent from all analyzed factors. It showed that oral propranolol administration in these patients combines optimal clinical results with relevant improvement of QoL, especially in cases of early management. The improvement of QoL seems unrelated to site of lesion, timing and duration of therapy, occurrence of drug-related adverse effects and persistence/recurrence of disease.

Pensabene, M., Di Pace, M.R., Baldanza, F., Grasso, F., Patti, M., Sergio, M., et al. (2022). Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas. THE ITALIAN JOURNAL OF PEDIATRICS, 48(1) [10.1186/s13052-022-01334-2].

Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas

Pensabene, Marco
Primo
;
Di Pace, Maria Rita
Secondo
;
Baldanza, Fabio;Grasso, Francesco;Sergio, Maria;La Placa, Simona;Giuffre’, Mario;Serra, Gregorio
;
Casuccio, Alessandra;Cimador, Marcello
Ultimo
2022-08-04

Abstract

Infantile hemangiomas may affect the quality of life (QoL) of patients and their family members, as anxiety and worry may commonly occur in parents, also linked to the social adversion they experience. We underline the beneficial impact of oral propranolol therapy on QoL of patients with infantile hemangiomas (IH) and of their relatives. A specific questionnaire measuring QoL was administered to parents of IH patients at beginning and end of a treatment with oral propranolol. Different aspects were investigated: site of the lesion, age of patients at starting therapy, length of treatment, occurrence of adverse effects and persistence/recurrence of the vascular anomaly. In all cases the questionnaire revealed a significant improvement of QoL, which was independent from all analyzed factors. It showed that oral propranolol administration in these patients combines optimal clinical results with relevant improvement of QoL, especially in cases of early management. The improvement of QoL seems unrelated to site of lesion, timing and duration of therapy, occurrence of drug-related adverse effects and persistence/recurrence of disease.
Pensabene, M., Di Pace, M.R., Baldanza, F., Grasso, F., Patti, M., Sergio, M., et al. (2022). Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas. THE ITALIAN JOURNAL OF PEDIATRICS, 48(1) [10.1186/s13052-022-01334-2].
File in questo prodotto:
File Dimensione Formato  
Infantile Hemangiomas.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 918.27 kB
Formato Adobe PDF
918.27 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/566255
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact